Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |